/R E P E A T -- Minister Guilbeault to Announce Funding for the Museum of Ingenuity J. Armand Bombardier in Valcourt/
The Honourable Steven Guilbeault, Minister of Canadian Heritage, will make an announcement on Thursday about the Museum of Ingenuity J. Armand Bombardier in Valcourt
VALCOURT, QC, Aug. 11, 2021 /CNW Telbec/ - The Honourable Steven Guilbeault, Minister of Canadian Heritage, will make an announcement on Thursday about the Museum of Ingenuity J. Armand Bombardier. This announcement will be made in person.
Places are limited, so journalists wishing to attend this press conference must confirm their attendance at [email protected] before 7 a.m. on Thursday, August 12.
Registered journalists will be able to ask the Minister questions following the press briefing.
Journalists attending the press conference in person must not have symptoms similar to COVID-19 or have been in contact with anyone who has tested positive in the last 14 days. It is mandatory to wear a mask.
Please note that all details are subject to change. All times are local.
The details are as follows:
DATE: Thursday, August 12, 2021
TIME: Announcement will start at 10 h 00 a.m.
LOCATION: Museum of Ingenuity J. Armand Bombardier 1001 J.-A.-Bombardier Avenue Valcourt, Quebec
The "Global Immune Health Supplements Market - Outlook & Forecast 2023-2028" report has been added to ResearchAndMarkets.com's offering.
The global immune health supplements market was valued at $20.80 billion in 2022 and is expected to reach...
The "Syndromic Multiplex Panels Markets. Strategies and Trends. Forecasts by Syndrome (Respiratory, Sepsis, GI etc.) by Place, by Product and by Country. With Market Analysis and Executive Guides. 2024 to 2028" report has been added to...
The "Immunoassay Markets. Strategies and Trends. Forecasts by Application, Technology, Product, User and by Country. With Executive Guides, Customized Forecasting and Analysis. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering....
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...